文献速递中医内科中药与中成药合理使用中医康复

COVID-19恢复期病理机制及中药治疗

The pathological mechanism of the COVID-19 convalescence and its treatment with traditional Chinese medicine.
PubMed 文献 · Front Pharmacol · 2023-01-10

综述探讨COVID-19恢复期病理机制,涉及免疫恢复不全、器官损伤、凝血异常、病毒二次打击和细胞衰老相关分泌表型等,并汇总中药在恢复期可缓解症状、改善指标和肺纤维化的证据,其中补肺活血胶囊是唯一被明确提及用于恢复期的药物。

要点

  • 恢复期症状复杂,机制未明,涉及免疫、凝血、器官损伤等多因素。
  • 中药可缓解恢复期症状并改善指标和肺纤维化。
  • 补肺活血胶囊对恢复期生理活动有康复作用。

核心结论

  • COVID-19恢复期临床症状复杂,发病机制尚未阐明。
  • 中药治疗恢复期有效,可缓解症状、改善指标和肺纤维化。

研究设计与样本

  • 检索PubMed近期关于COVID-19恢复期的文章进行综述。

主要发现

  • 恢复期机制可能与免疫系统恢复不全、肝或肺实质器官损伤、凝血异常、病毒感染二次打击及细胞衰老相关分泌表型现象有关。
  • 部分药物和心理因素也起不可忽视的作用。
  • 补肺活血胶囊是唯一明确提及用于COVID-19恢复期的药物,对恢复期患者生理活动有强康复作用。
  • 中药被证实可抗细胞因子风暴、改善凝血和心肌损伤。

临床怎么用

  • 恢复期患者可考虑中药治疗以缓解症状、改善指标和肺纤维化。
  • 补肺活血胶囊可用于COVID-19恢复期康复。

局限性

  • 中药具体作用和机制需更多研究证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The severe acute respiratory syndrome coronavirus - 2 (SARS - CoV - 2) was reported to cause the Wuhan outbreak of the corona virus disease 2019(COVID-19). To date, the COVID-19 has infected more than 600 million people gloabally. As a growing number of patients recover from acute infections and are discharged from hospitals, the proportion of patients in the recovery period is gradually increasing. Many of these individuals have been reported to experience multiple symptoms during the convalescence, such as fatigue, dyspnea and pain which are designated as "long-COVID", "post-COVID syndrome" or "recovery sequelae. We searched for recent articles published in PubMed on COVID-19 convalescence and found that the pathogenesis of COVID-19 convalescence is not yet well recognized. It may be associated with incomplete recovery of immune system, parenchymal organ damage (liver or lung), coagulation abnormalities, "second hit" caused by viral infection, and Phenomenon of Cell Senescence-Associated Secretory Phenotype (SASP). Some drugs and psychological factors of patients also play a non-negligible role in it. We also found that the effect of traditional Chinese medicine (TCM) is effective in the treatment of the COVID-19 recovery phase, which can not only relieve the corresponding symptoms, but also improve the indicators and pulmonary fibrosis. Bufei Huoxue Capsule, as the only drug explicitly mentioned for COVID-19 recovery period, can exert strong rehabilitative effects on physiological activity in patients recovering from COVID-19. In addition, in previous studies, traditional Chinese medicine has been confirmed to have the ability to resist cytokine storms, as well as improve coagulation and myocardial damage, which makes it have potential therapeutic advantages in targeting the hyperimmune response, coagulation abnormalities and myocardial damage existing in the recovery period. In conclusion, the clinical symptoms of patients convalescing from COVID-19 are complex, and its pathogenesis has not been elucidated. traditional Chinese medicine, as a traditional treatment, its specific action and mechanism need to be confirmed by more studies, so that it can play a better role.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Jiang L, An X, Duan Y, et al. The pathological mechanism of the COVID-19 convalescence and its treatment with traditional Chinese medicine. Front Pharmacol. 2023. PMID: 36703736. doi:10.3389/fphar.2022.1054312

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。